This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Synchrony (SYF) & Veterinary Growth to Offer Pet Care Financing
by Zacks Equity Research
Synchrony (SYF) collaborates with Veterinary Growth to provide pet care financing solutions to its members.
Should You Buy Globe Life (GL) Stock for Better Returns Now?
by Zacks Equity Research
Globe Life's (GL) higher premiums, new investment yields, strong liquidity position, favorable estimates and effective capital deployment poise it well for growth.
Globe Life (GL) is a Top-Ranked Momentum Stock: Should You Buy?
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Moody's (MCO) Rides on Strategic Acquisitions Amid Cost Woes
by Zacks Equity Research
Focus on diversifying revenue base and inorganic expansion initiatives are likely to support Moody's (MCO). However, rising expenses and intense competition are headwinds.
Here's Why You Should Invest in Globe Life (GL) Stock Now
by Zacks Equity Research
Globe Life's (GL) higher premiums, new investment yields, strong liquidity position, favorable estimates and effective capital deployment poise it well for growth.
Why Investors are Retaining American Express (AXP) Stock Now
by Zacks Equity Research
American Express' (AXP) focus on small and medium-sized enterprises positions it for long-term growth.
Globe Life (GL) Up 0.3% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Globe Life (GL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Rithm (RITM) & Partners to Buy $120M BTR Project in Virginia
by Zacks Equity Research
Through its strategic partnership with GreenBarn, Rithm (RITM) is expected to provide equity capital for the BTR project.
Synchrony Financial (SYF) Up 10% in 3 Months: Growth Ahead?
by Zacks Equity Research
Synchrony Financial's (SYF) focus on creating new partnerships and expanding old ones is expected to position the company for long-term growth.
Rithm Capital Corp. (RITM) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Rithm (RITM) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
PRA Group (PRAA) Q2 Loss Relieved by Lower Operating Costs
by Zacks Equity Research
PRA Group (PRAA) expects compensation expenses to be in the mid-$70 million range in the third quarter.
Globe Life (GL) Q2 Earnings Top Estimates, Premiums Rise Y/Y
by Zacks Equity Research
Globe Life's (GL) second-quarter results reflect higher premiums and increased net investment income. Higher expenses and lower insurance underwriting income are the offsets.
Globe Life (GL) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Globe Life (GL) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Globe Life (GL) Beats Q2 Earnings Estimates
by Zacks Equity Research
Globe Life (GL) delivered earnings and revenue surprises of 1.56% and 0.01%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
What's in the Cards for Willis Towers (WTW) in Q2 Earnings?
by Zacks Equity Research
Willis Towers' (WTW) second-quarter results are likely to have reflected gains from reward-based advisory services, higher levels of project work, and the expansion of local portfolios and lower expenses.
Will Rising Costs Hurt Kinsale Capital's (KNSL) Q2 Earnings?
by Zacks Equity Research
Kinsale Capital's (KNSL) second-quarter results are likely to have reflected higher net premiums earned and investment income.
Globe Life (GL) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Globe Life (GL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why Globe Life (GL) is a Strong Growth Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Avantax (AVTA) Surges 6.0%: Is This an Indication of Further Gains?
by Zacks Equity Research
Avantax (AVTA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Why Globe Life (GL) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why You Should Hold Globe Life (GL) in Your Portfolio
by Zacks Equity Research
Globe Life's (GL) strong segmental performance, improving net investment income and positive 2023 outlook poise it well for growth.
Globe Life (GL) Down 2% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Globe Life (GL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Globe Life (GL) Q1 Earnings Beat, Revenues Miss Estimates
by Zacks Equity Research
Globe Life's (GL) first-quarter results reflect higher premiums, increased net investment income and improved insurance underwriting income. Higher expenses act as offsets.
Globe Life (GL) Reports Q1 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
While the top- and bottom-line numbers for Globe Life (GL) give a sense of how the business performed in the quarter ended March 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.